Skip to Content
Jump to the top of the page

William Blair Thinking

  • Inside the AI Economy: Competition, Compute, and the Next Phase of Enterprise Adoption

    William Blair's Arjun Bhatia and Jonathan Ho discuss the latest developments shaping the AI landscape, from intensifying model competition and pricing pressure to data center expansion, cybersecurity risks, and the pace of enterprise adoption.

    Listen to the podcast
  • The Quarterly Rx: Q2 2026 U.S. Biopharma Recap

    In our Q2 2026 U.S. Biopharma Recap, the William Blair biopharma team reviews the quarter’s financing, strategic activity, and investor sentiment trends shaping the sector for the remainder of the year.

    Read more
  • AI’s Biggest Healthcare Impact Isn’t Where You Think

    Despite excitement around drug development, AI’s most tangible healthcare benefits today are in reducing administrative burden and enhancing diagnostic imaging.

    Watch the video

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Recognizing Our 2026 William Blair Cares Awards Recipients

    We are pleased to announce the recipients of the 2026 William Blair Cares Awards, our annual program recognizing the exceptional volunteer efforts and impact of our colleagues across the firm.

    Read more
  • Advanced Micro Devices, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Advanced Micro Devices, Inc. (AMD $516.11), a semiconductor company that designs chips including CPUs, GPUs, and a range of other processors for data center, industrial, and consumer use.

    Read more
  • Zura Bio Limited: Initiation of Research Coverage

    William Blair initiated research coverage of Zura Bio Limited (ZURA $5.36), a clinical-stage biotechnology company developing the bispecific antibody tibulizumab (IL-17xBAFF) for the treatment of autoimmune diseases.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures